Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Ekstraco ApS
APS
Active
CVR 39567326
Funder Bakke 28
Manufacture of pharmaceutical preparations · NACE 2120
Est. 2018
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK -7K
-11% vs 2023
EBITDA margin
100.0%
+11% vs 2023
Equity ratio
-46719.0%
Financial strength
Net profit 2024
DKK -9K
+7% vs 2023
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2018
0M
0%
2019
0M
0%
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
DKK -7K
-11%
EBITDA
DKK -7K
+11%
Net profit
DKK -9K
+7%
Total assets
DKK 116
-95%
Equity
DKK -54K
-20%
Employees
—
—
Company information
Legal name
Ekstraco ApS
CVR number
39567326
Legal form
Anpartsselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
14. maj 2018
Share capital
DKK 40.050
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af direktøren
Company purpose
Virksomhedens formål er at ekstrahere værdistoffer fra grøn biomasse.
Contact
Address
Funder Bakke 28
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Manufacture of pharmaceutical preparations
Companies in Silkeborg
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2018
0M
2019
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2018
0M
2019
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
DKK thousands
Item
2018
2019
2020
2021
2022
2023
2024
Revenue
0
0
-5
-63
-5
-8
-7
Staff expenses
-0
-0
-0
-0
-0
-0
-0
EBITDA
0
0
-5
-63
-5
-8
-7
Depreciation & amort.
-0
-0
-0
-0
-0
-0
-0
EBIT
0
0
-5
-63
-5
-8
-7
Net financials
0
0
-0
-0
-2
-2
-2
Profit before tax
0
0
-5
-63
-8
-10
-9
Tax
-0
-0
-0
-0
-0
-0
-0
Net profit
0
0
-5
-63
-8
-10
-9
Balance sheet
DKK thousands
Item
2018
2019
2020
2021
2022
2023
2024
Total assets
0
0
72
89
7
2
0
Equity
0
0
-5
-28
-36
-45
-54
Long-term debt
0
0
0
0
0
0
0
Short-term debt
0
0
77
117
43
48
54
Total debt
0
0
77
117
43
48
54
Financial ratios
5-year trend
EBITDA margin
-722100.0%
This company
15.8%
Market median
-4570353% vs market
2018
2024
Equity ratio
-46719.0%
This company
38.2%
Market median
-122401% vs market
2018
2024
Return on equity
-900400.0%
This company
18.4%
Market median
-4893578% vs market
2018
2024
Net profit margin
-900400.0%
This company
8.1%
Market median
-11116149% vs market
2018
2024
Asset turnover
-62.25×
This company
1.12×
Market median
-5658% vs market
2018
2024
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
2018
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via CVR / Virk · Period 2018-05-14 – 2018-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
TN
Thomas Nørding
Management
Management
2018
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
NOERDING ApS
Company
100.0%
100.0%
2018
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
NOERDING ApS
Ekstraco ApS
(this company)
Board network connections
Board members of Ekstraco ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Thomas Nørding
Management
0 companies